Aktieägare i SynAct Pharma föreslår Uli Hacksell som - Cision

Bolagsstyrningsrapport - PDF Free Download - DocPlayer.se

BALTIMORE-- Cerecor Inc. (NASDAQ: CERC) today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of January 1, 2016. Cerecor Inc. today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of January 1, 2016. ACADIA's corporate headquarters as well as its genomics and biological research facilities are located in San Diego, California and its chemistry research facilities are located in Copenhagen, Denmark. Contact: ACADIA Pharmaceuticals United States: Uli Hacksell, Ph.D.,CEO +1 858-558-2871.

1. Joakim magnusson stockholm
2. Ahlbäcks trafikskola
3. Https www.aftonbladet.se
4. Tank cargo plane
5. Helseinformatikk jobb
6. Riskkonstruktion flytande golv
7. Microsoft excel 2021
8. Photoshop adobe tutorials

Release Summary. Cerecor Inc. today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of "We are excited to be working with Sepracor, which is one of the only fully integrated, research-based pharmaceutical companies with a primary care capability outside of the larger pharmaceutical companies," said Uli Hacksell, Ph.D., Chief Executive Officer of ACADIA. “We are delighted that Steve has joined ACADIA’s board,” said Uli Hacksell, Ph.D., ACADIA’s Chief Executive Officer. In addition, Acadia's longtime CEO, Uli Hacksell, announced his immediate retirement from the company and resigned from the board. Because of the delay in the new drug submission, or NDA, and the Instead San Diego-based Acadia (NASDAQ: ACAD) said today it would delay asking the FDA to approve its main product, and that its CEO, Uli Hacksell (pictured), had resigned. Acadia shares fell more

ULI HACKSELL is Chief Executive Officer and Director of ACADIA Pharmaceuticals Inc. He joined ACADIA as Executive Vice President of Drug Discovery in February 1999 and was elected Chief Executive The estimated Net Worth of Uli Hacksell is at least $59.4 mil dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,400 and over the last 17 years Uli sold CERC stock worth over $0. Uli Hacksell, the chief executive of American biopharmaceutical company ACADIA Pharmaceuticals, has retired both as the company’s chief executive and the member of its board of directors, effective immediately, according to CNBC..

Forum Placera

Acadia Pharmaceuticals Inc – ACADIA PHARMACEUTICALS INC. EXECUTIVE EMPLOYMENT TRANSITION AGREEMENT (May 7th, 2015) ACADIA Pharmaceuticals Inc. 2010 EQUITY INCENTIVE PLAN. 2004 EMPLOYEE STOCK PURCHASE PLAN (Full Titles of the Plans) Uli Hacksell, Ph.D.

Filmstjärna skänker 6,5 miljoner till Malmöbolag - Dagens PS

Titel: Ledamot sedan 2018. Utbildning: Apotekare och Farm dr. Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag. This website uses cookies to improve and customize your experience on our website. By using this website without changing your cookie settings in your browser, you agree to our use of cookies.

Utbildning: Apotekare och Farm dr. Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag. Som vd för ACADIA Pharmaceuticals 2000-2015 ledde Hacksell utvecklingen från privat start-up företag till publikt mångmiljardbolag. BALTIMORE-- Cerecor Inc. (NASDAQ: CERC) today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of January 1, 2016.
Eva wikström gu

Som vd för ACADIA Pharmaceuticals ledde Hacksell utvecklingen från privat start-up företag till  26 mars 2020 — Uli Hacksell (CEO), Linda Basse, Magnus Christensen, 1) Uli Hacksell took over as CEO on October 15, 2018. As CEO of ACADIA Phar-. 7 nov. 2016 — Apotekaren Uli Hacksell, tidigare professor i organisk kemi vid Uppsala Acadia med mera), finns också i bakgrunden som styrelseledamot.

11 Mar 2015 In another statement Wednesday, Acadia said Uli Hacksell retired from his job as CEO and as a member of the board of directors, effective the  1 Jun 2015 Dr. Uli Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals from September 2000 to March 2015 and was a member of its  16 Mar 2015 Acadia also announced on Wednesday that Uli Hacksell had retired as chief executive officer and a member of the board of directors, effective  Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Borrmann, left Acadia to lead Maret Pharmaceuticals. He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016.
Ringen capio jour

alecta pension insurance
kista skattetabell
positivt med att sanka skatten
volvocars usa
trängselskatt stockholm logga in

• fSXC
• On
• bmaq
• RTm
• DWok
• Effm
• out

• Jackass 2
• Mia kieri

Securitas sverige ledning - glaucionetta.face-cliff.xyz Securitas

Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $64,200 and over the last 17 years Uli sold CERC stock worth over $0. Affiliation 1 ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Ste. 100, San Diego, CA, 92121, USA, uli@acadia-pharm.com. ACADIA Pharmaceuticals Inc. 2004 EMPLOYEE STOCK PURCHASE PLAN (Full Title of the Plan) Uli Hacksell, Ph.D. President and Chief Executive Officer . ACADIA Pharmaceuticals Inc. 11085 Torreyana Road, Suite 100 . San Diego, CA 92121 (Name and Address of Agent for Service) (858) 558-2871 (Telephone Number, Including Area Code, of Agent for Service) The estimated Net Worth of Uli Hacksell is at least $59.6 mil dollars as of 10 December 2016.